There is strong evidence linking the involvement of S1P receptors (S1PRs) in cancer progression, and the oncogenic effects of S1P can result from alterations in the expression of one or more of the S1PRs and/or the enzymes that regulate the levels of S1P. The gene discussed is MBTPS1; the disease is cancer.